Autopsy report · NCT02250924

Caffeinated Gum to Prevent Post-Operative Ileus: A Prospective, Randomized, Placebo-controlled Trial

“Investigator decision - clinical practice change”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

The Guthrie Clinic

Sponsor type

University, hospital or other

Conditions

C.Surgical Procedure; Digestive System

Interventions

Caffeine; Gum; wear silicone bracelet

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Prognosis of Behavioral Addiction in Parkinson's Disease
  “Investigator's decision” (73% match in meaning)
• A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension
  “Decision to change the study design” (67% match in meaning)
• Optical Brain Pulse Monitor: Validation Of Cerebral Oximetry Monitoring (OBPM:VOCOM) Study.
  “The decision was made to withdraw this study prior to recruitment to make further changes to the investigational device.” (65% match in meaning)
• Implication of a Mobile Team of Palliative Care and Reality of the Palliative Approach in the Units
  “Investigator's decision (departure from Institution)” (65% match in meaning)
• A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection Therapy
  “Change in clinical strategy” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.